CENTRAL LINE INFECTION side effect
What is CENTRAL LINE INFECTION ?Drugs associated with CENTRAL LINE INFECTION
ACIPHEX ALDESLEUKIN ALDURAZYME ARANESP AVONEX BENICAR BUSULFAN CEREZYME CISPLATIN CYTARABINE DOXORUBICIN ENBREL ERLOTINIB FABRAZYME FLOLAN FLUOROURACIL FORTEO FOSAMAX HEPARIN HUMIRA IBANDRONIC INTRALIPID METOPROLOL MYOZYME NEUPOGEN OXALIPLATIN PANITUMUMAB PEGINTERFERON PENTASA PROGRAF REMODULIN REVLIMID TRACLEER TYGACIL TYSABRICENTRAL LINE INFECTION : Fabrazyme Side Effects Report #5664328-X
Consumer or non-health professional from UNITED STATES reported FABRAZYME problem on Mar 03, 2008. Male patient, 35 years of age, weighting 154.3 lb, was diagnosed with fabry's disease and was treated with FABRAZYME. After drug was administered, patient experienced the following problems/side effects: central line infection, urinary tract obstruction, . FABRAZYME dosage: 1 MG/KG, Q2W, INTRAVENOUS. Patient was hospitalized. Patient recovered.
CENTRAL LINE INFECTION : Humira Side Effects Report #5666879-0
HUMIRA problem was reported by a Health Professional from UNITED STATES on Jan 02, 2008. Female patient, 47 years of age, was diagnosed with crohn's disease and was treated with HUMIRA. After drug was administered, patient experienced the following problems/side effects: central line infection, injection site pain, . HUMIRA dosage: unknown. Patient recovered.
CENTRAL LINE INFECTION : Tysabri Side Effects Report #5671025-3
Health Professional from UNITED STATES reported TYSABRI problem on Mar 06, 2008. Female patient, 43 years of age, was diagnosed with multiple sclerosis and was treated with TYSABRI. After drug was administered, patient experienced the following problems/side effects: central line infection, gastric ulcer, obstruction gastric, post procedural infection, staphylococcal sepsis, upper gastrointestinal haemorrhage, . TYSABRI dosage: 300 MG; QM; IV. Patient was hospitalized. Patient recovered.
CENTRAL LINE INFECTION : Ibandronic Side Effects Report #5674217-2
IBANDRONIC ACID problem was reported by a Physician from GERMANY on Mar 13, 2008. Male patient, 38 years of age, weighting 154.3 lb, was treated with IBANDRONIC ACID. After drug was administered, patient experienced the following problems/side effects: central line infection, ill-defined disorder, . IBANDRONIC ACID dosage: unknown. During the same period patient was treated with BEVACIZUMAB, PACLITAXEL, LEVOFLOXACIN. Patient was hospitalized. Patient recovered.
CENTRAL LINE INFECTION : Flolan Side Effects Report #5682837-4
Consumer or non-health professional from UNITED STATES reported FLOLAN problem on Mar 19, 2008. Female patient, 50 years of age, was treated with FLOLAN. After drug was administered, patient experienced the following problems/side effects: central line infection, vision blurred, visual disturbance, . FLOLAN dosage: unknown. During the same period patient was treated with STARLIX, SYNTHROID, CEFTIN. Patient was hospitalized. Patient recovered.
CENTRAL LINE INFECTION : Aranesp Side Effects Report #5630474-X
ARANESP problem was reported by a Health Professional from AUSTRALIA on Feb 06, 2008. Male patient, weighting 165.3 lb, was diagnosed with dialysis, renal failure chronic and was treated with ARANESP. After drug was administered, patient experienced the following problems/side effects: central line infection, haemoglobin increased, lymphopenia, neutrophilia, . ARANESP dosage: unknown. During the same period patient was treated with OMEPRAZOLE, CALTRATE, CALCITRIOL, MYLANTA, SENSIPAR. Patient was hospitalized. Patient recovered.
CENTRAL LINE INFECTION : Prograf Side Effects Report #5635847-7
Physician from JAPAN reported PROGRAF problem on Feb 08, 2008. Female patient, 26 years of age, weighting 92.59 lb, was diagnosed with small intestine transplant and was treated with PROGRAF. After drug was administered, patient experienced the following problems/side effects: central line infection, dehydration, electrolyte imbalance, renal impairment, sepsis, small intestinal stenosis, transplant rejection, . PROGRAF dosage: unknown. During the same period patient was treated with MEDROL, ROHYPNOL, MARZULENE S, LANSOPRAZOLE. Patient recovered.
CENTRAL LINE INFECTION : Heparin Side Effects Report #5581603-8
HEPARIN LOCK problem was reported by a Consumer or non-health professional from UNITED STATES on Jan 03, 2008. Female patient, weighting 120.0 lb, was diagnosed with localised infection and was treated with HEPARIN LOCK. After drug was administered, patient experienced the following problems/side effects: central line infection, chills, colitis ischaemic, malaise, pollakiuria, pyrexia, . HEPARIN LOCK dosage: 5 ML IN 12 ML SYRINGE 1 X DAILY. Patient was hospitalized. Patient recovered.
CENTRAL LINE INFECTION : Avonex Side Effects Report #5607400-2
Consumer or non-health professional from UNITED STATES reported AVONEX problem on Jan 15, 2008. Female patient, 53 years of age, was diagnosed with multiple sclerosis and was treated with AVONEX. After drug was administered, patient experienced the following problems/side effects: central line infection, fall, foot fracture, localised infection, . AVONEX dosage: unknown. Patient was hospitalized. Patient recovered.
CENTRAL LINE INFECTION : Enbrel Side Effects Report #5556714-3
ENBREL problem was reported by a Consumer or non-health professional from UNITED STATES on Sept 24, 2007. Female patient was diagnosed with rheumatoid arthritis and was treated with ENBREL. After drug was administered, patient experienced the following problems/side effects: central line infection, rheumatoid arthritis, . ENBREL dosage: unknown. During the same period patient was treated with CIPRO. Patient recovered.
CENTRAL LINE INFECTION : Aciphex Side Effects Report #5578751-5
Physician from UNITED STATES reported ACIPHEX problem on Dec 13, 2007. Female patient, 76 years of age, weighting 183.0 lb, was diagnosed with gastrooesophageal reflux disease and was treated with ACIPHEX. After drug was administered, patient experienced the following problems/side effects: central line infection, colitis ischaemic, sepsis, . ACIPHEX dosage: 20 MG, ORAL. During the same period patient was treated with LIDICAIN VISCOUS, SERTRALINE, ASPIRIN, FLAGIL, CIPRO, ACETAMINOPHEN, DARVOCIT, LANTUS. Patient was hospitalized. Patient died on 11/20/2007.
CENTRAL LINE INFECTION : Aciphex Side Effects Report #5579313-6
ACIPHEX problem was reported by a Physician from UNITED STATES on Dec 13, 2007. Female patient, 76 years of age, weighting 183.0 lb, was diagnosed with gastrooesophageal reflux disease and was treated with ACIPHEX. After drug was administered, patient experienced the following problems/side effects: central line infection, colitis ischaemic, renal failure chronic, sepsis, . ACIPHEX dosage: 20 MG, ORAL. During the same period patient was treated with LIDOCAINE VISCOUS, SERTRALINE, ASPIRIN, PLAXIC, FLAGIL, CIPRO, ACETAMINOPHEN, DARVOCIT. Patient was hospitalized. Patient died on 11/20/2007.
CENTRAL LINE INFECTION : Intralipid Side Effects Report #5517736-1
Consumer or non-health professional from UNITED STATES reported INTRALIPID problem on Nov 01, 2007. Male patient was diagnosed with parenteral nutrition and was treated with INTRALIPID. After drug was administered, patient experienced the following problems/side effects: central line infection, device failure, staphylococcal infection, . INTRALIPID dosage: unknown. Patient recovered.
CENTRAL LINE INFECTION : Cytarabine Side Effects Report #5534135-7
CYTARABINE problem was reported by a Consumer or non-health professional from UNITED STATES on Nov 29, 2007. Male patient, weighting 158.7 lb, was treated with CYTARABINE. After drug was administered, patient experienced the following problems/side effects: central line infection, pseudomonas infection, staphylococcal infection, . CYTARABINE dosage: 28800 MG. During the same period patient was treated with ETOPOSIDE. Patient was hospitalized. Patient recovered.
CENTRAL LINE INFECTION : Cytarabine Side Effects Report #5534137-0
Consumer or non-health professional from UNITED STATES reported CYTARABINE problem on Nov 29, 2007. Male patient, weighting 158.7 lb, was treated with CYTARABINE. After drug was administered, patient experienced the following problems/side effects: central line infection, pseudomonas infection, staphylococcal infection, . CYTARABINE dosage: 28800 MG. During the same period patient was treated with ETOPOSIDE. Patient was hospitalized. Patient recovered.
CENTRAL LINE INFECTION : Neupogen Side Effects Report #5478025-7
NEUPOGEN problem was reported by a Health Professional from FRANCE on Sept 24, 2007. Male patient, 45 years of age, was diagnosed with neutropenia and was treated with NEUPOGEN. After drug was administered, patient experienced the following problems/side effects: central line infection, dermatitis exfoliative, dysphagia, enterococcal infection, escherichia bacteraemia, lymphangitis, metabolic acidosis, pyrexia, rash scarlatiniform, . NEUPOGEN dosage: unknown. During the same period patient was treated with TARGOCID, VALGANCICLOVIR, KIVEXA, NORVIR, SUSTIVA, PREZISTA, IMOVANE, LEXOMIL. Patient was hospitalized. Patient recovered.
CENTRAL LINE INFECTION : Panitumumab Side Effects Report #5478419-X
Physician from UNITED STATES reported PANITUMUMAB problem on Sept 26, 2007. Female patient was diagnosed with colorectal cancer and was treated with PANITUMUMAB. After drug was administered, patient experienced the following problems/side effects: central line infection, febrile neutropenia, . PANITUMUMAB dosage: unknown. During the same period patient was treated with IRINOTECAN. Patient was hospitalized. Patient recovered.
CENTRAL LINE INFECTION : Avonex Side Effects Report #5494234-5
AVONEX problem was reported by a Consumer or non-health professional from UNITED STATES on Oct 12, 2007. Female patient, 53 years of age, was diagnosed with multiple sclerosis and was treated with AVONEX. After drug was administered, patient experienced the following problems/side effects: central line infection, fall, foot fracture, localised infection, . AVONEX dosage: unknown. Patient was hospitalized. Patient recovered.
CENTRAL LINE INFECTION : Forteo Side Effects Report #5448541-2
Consumer or non-health professional from UNITED STATES reported FORTEO problem on Sept 04, 2007. Female patient was treated with FORTEO. After drug was administered, patient experienced the following problems/side effects: central line infection, dehydration, septic shock, . FORTEO dosage: unknown. Patient was hospitalized. Patient died on 04/28/2007.
CENTRAL LINE INFECTION : Cytarabine Side Effects Report #5456215-7
CYTARABINE problem was reported by a Consumer or non-health professional from UNITED STATES on Sept 14, 2007. Male patient, weighting 190.0 lb, was treated with CYTARABINE. After drug was administered, patient experienced the following problems/side effects: central line infection, deep vein thrombosis, platelet count decreased, . CYTARABINE dosage: unknown. Patient was hospitalized. Patient recovered.
CENTRAL LINE INFECTION : Cytarabine Side Effects Report #5456763-X
Consumer or non-health professional from UNITED STATES reported CYTARABINE problem on Sept 17, 2007. Male patient, weighting 190.0 lb, was treated with CYTARABINE. After drug was administered, patient experienced the following problems/side effects: central line infection, deep vein thrombosis, platelet count decreased, . CYTARABINE dosage: unknown. Patient was hospitalized. Patient recovered.
CENTRAL LINE INFECTION : Panitumumab Side Effects Report #5459417-9
PANITUMUMAB problem was reported by a Physician from UNITED STATES on Sept 12, 2007. Female patient was diagnosed with colorectal cancer and was treated with PANITUMUMAB. After drug was administered, patient experienced the following problems/side effects: central line infection, neutropenia, . PANITUMUMAB dosage: unknown. During the same period patient was treated with IRINOTECAN. Patient was hospitalized. Patient recovered.
CENTRAL LINE INFECTION : Avonex Side Effects Report #5463661-4
Consumer or non-health professional from UNITED STATES reported AVONEX problem on Sept 11, 2007. Male patient, 45 years of age, was diagnosed with multiple sclerosis and was treated with AVONEX. After drug was administered, patient experienced the following problems/side effects: central line infection, grand mal convulsion, renal failure, yellow skin, . AVONEX dosage: unknown. Patient was hospitalized. Patient recovered.
CENTRAL LINE INFECTION : Tygacil Side Effects Report #5421022-8
TYGACIL problem was reported by a Physician from UNITED STATES on Aug 14, 2007. Female patient, weighting 185.2 lb, was diagnosed with abdominal abscess, sepsis and was treated with TYGACIL. After drug was administered, patient experienced the following problems/side effects: central line infection, staphylococcal infection, . TYGACIL dosage: unknown. During the same period patient was treated with DIFLUCAN, LEVAQUIN. Patient was hospitalized. Patient recovered.
CENTRAL LINE INFECTION : Fluorouracil Side Effects Report #5385120-X
Consumer or non-health professional from UNITED STATES reported FLUOROURACIL problem on July 06, 2007. Female patient, weighting 134.9 lb, was diagnosed with pancreatic carcinoma and was treated with FLUOROURACIL. After drug was administered, patient experienced the following problems/side effects: central line infection, . FLUOROURACIL dosage: 2400 MG/M2 OVER 48 HRS IV AMBULATORY PUMP. During the same period patient was treated with BEVACIZUMAB. Patient was hospitalized. Patient recovered.
CENTRAL LINE INFECTION : Aldurazyme Side Effects Report #5390726-8
ALDURAZYME problem was reported by a Pharmacist from GERMANY on Mar 09, 2006. Female patient was diagnosed with mucopolysaccharidosis i and was treated with ALDURAZYME. After drug was administered, patient experienced the following problems/side effects: central line infection, lung disorder, streptococcal infection, . ALDURAZYME dosage: unknown. Patient was hospitalized. Patient recovered.
CENTRAL LINE INFECTION : Aldurazyme Side Effects Report #5390727-X
Health Professional from UNITED KINGDOM reported ALDURAZYME problem on Feb 22, 2006. Female patient was diagnosed with mucopolysaccharidosis i and was treated with ALDURAZYME. After drug was administered, patient experienced the following problems/side effects: central line infection, . ALDURAZYME dosage: unknown. Patient recovered.
CENTRAL LINE INFECTION : Aldurazyme Side Effects Report #5390956-5
ALDURAZYME problem was reported by a Health Professional from UNITED STATES on July 27, 2006. Female patient, weighting 18.54 lb, was diagnosed with mucopolysaccharidosis i and was treated with ALDURAZYME. After drug was administered, patient experienced the following problems/side effects: central line infection, human t-cell lymphotropic virus infection, . ALDURAZYME dosage: 11.6 MG Q2WKS IV. Patient was hospitalized. Patient recovered.
CENTRAL LINE INFECTION : Aldurazyme Side Effects Report #5390962-0
Health Professional from UNITED STATES reported ALDURAZYME problem on Apr 30, 2007. Female patient was diagnosed with mucopolysaccharidosis ih and was treated with ALDURAZYME. After drug was administered, patient experienced the following problems/side effects: central line infection, lung neoplasm, staphylococcal sepsis, . ALDURAZYME dosage: 0.58 MG/MG QWK IV. Patient recovered.
CENTRAL LINE INFECTION : Remodulin Side Effects Report #5403702-3
REMODULIN problem was reported by a Health Professional from UNITED STATES on May 08, 2007. Female patient, 45 years of age, weighting 163.1 lb, was diagnosed with pulmonary hypertension and was treated with REMODULIN. After drug was administered, patient experienced the following problems/side effects: central line infection, . REMODULIN dosage: unknown. During the same period patient was treated with OVCON, TRACLEER, WARFARIN, FLONASE. Patient was hospitalized. Patient recovered.
CENTRAL LINE INFECTION : Remodulin Side Effects Report #5404787-0
Health Professional from UNITED STATES reported REMODULIN problem on Apr 19, 2007. Female patient, 36 years of age, weighting 154.3 lb, was diagnosed with pulmonary hypertension and was treated with REMODULIN. After drug was administered, patient experienced the following problems/side effects: central line infection, . REMODULIN dosage: unknown. During the same period patient was treated with SILDENAFIL CITRATE, LASIX, SPIRONOLACTONE, DIGOXIN, LOPERAMIDE, ONDANSETRON, ZOLPIDEM TARTRATE, LORTAB. Patient recovered.
CENTRAL LINE INFECTION : Fluorouracil Side Effects Report #5385120-X
FLUOROURACIL problem was reported by a Consumer or non-health professional from UNITED STATES on July 06, 2007. Female patient, weighting 134.9 lb, was diagnosed with pancreatic carcinoma and was treated with FLUOROURACIL. After drug was administered, patient experienced the following problems/side effects: central line infection, . FLUOROURACIL dosage: 2400 MG/M2 OVER 48 HRS IV AMBULATORY PUMP. During the same period patient was treated with BEVACIZUMAB. Patient was hospitalized. Patient recovered.
CENTRAL LINE INFECTION : Aldurazyme Side Effects Report #5390726-8
Pharmacist from GERMANY reported ALDURAZYME problem on Mar 09, 2006. Female patient was diagnosed with mucopolysaccharidosis i and was treated with ALDURAZYME. After drug was administered, patient experienced the following problems/side effects: central line infection, lung disorder, streptococcal infection, . ALDURAZYME dosage: unknown. Patient was hospitalized. Patient recovered.
CENTRAL LINE INFECTION : Aldurazyme Side Effects Report #5390727-X
ALDURAZYME problem was reported by a Health Professional from UNITED KINGDOM on Feb 22, 2006. Female patient was diagnosed with mucopolysaccharidosis i and was treated with ALDURAZYME. After drug was administered, patient experienced the following problems/side effects: central line infection, . ALDURAZYME dosage: unknown. Patient recovered.
CENTRAL LINE INFECTION : Aldurazyme Side Effects Report #5390956-5
Health Professional from UNITED STATES reported ALDURAZYME problem on July 27, 2006. Female patient, weighting 18.54 lb, was diagnosed with mucopolysaccharidosis i and was treated with ALDURAZYME. After drug was administered, patient experienced the following problems/side effects: central line infection, human t-cell lymphotropic virus infection, . ALDURAZYME dosage: 11.6 MG Q2WKS IV. Patient was hospitalized. Patient recovered.
CENTRAL LINE INFECTION : Aldurazyme Side Effects Report #5390962-0
ALDURAZYME problem was reported by a Health Professional from UNITED STATES on Apr 30, 2007. Female patient was diagnosed with mucopolysaccharidosis ih and was treated with ALDURAZYME. After drug was administered, patient experienced the following problems/side effects: central line infection, lung neoplasm, staphylococcal sepsis, . ALDURAZYME dosage: 0.58 MG/MG QWK IV. Patient recovered.
CENTRAL LINE INFECTION : Remodulin Side Effects Report #5403702-3
Health Professional from UNITED STATES reported REMODULIN problem on May 08, 2007. Female patient, 45 years of age, weighting 163.1 lb, was diagnosed with pulmonary hypertension and was treated with REMODULIN. After drug was administered, patient experienced the following problems/side effects: central line infection, . REMODULIN dosage: unknown. During the same period patient was treated with OVCON, TRACLEER, WARFARIN, FLONASE. Patient was hospitalized. Patient recovered.
CENTRAL LINE INFECTION : Remodulin Side Effects Report #5404787-0
REMODULIN problem was reported by a Health Professional from UNITED STATES on Apr 19, 2007. Female patient, 36 years of age, weighting 154.3 lb, was diagnosed with pulmonary hypertension and was treated with REMODULIN. After drug was administered, patient experienced the following problems/side effects: central line infection, . REMODULIN dosage: unknown. During the same period patient was treated with SILDENAFIL CITRATE, LASIX, SPIRONOLACTONE, DIGOXIN, LOPERAMIDE, ONDANSETRON, ZOLPIDEM TARTRATE, LORTAB. Patient recovered.
CENTRAL LINE INFECTION : Peginterferon Side Effects Report #5679740-2
Consumer or non-health professional from UNITED KINGDOM reported PEGINTERFERON ALFA problem on Mar 13, 2008. Male patient, child 12 years of age, weighting 55.12 lb, was diagnosed with metastases to lung and was treated with PEGINTERFERON ALFA. After drug was administered, patient experienced the following problems/side effects: arthritis bacterial, central line infection, device related infection, staphylococcal infection, . PEGINTERFERON ALFA dosage: unknown. Patient was hospitalized. Patient recovered.
CENTRAL LINE INFECTION : Cerezyme Side Effects Report #5688159-X
CEREZYME problem was reported by a Physician from JAPAN on Mar 21, 2008. Female patient, child 8 years of age, weighting 26.46 lb, was diagnosed with gaucher's disease and was treated with CEREZYME. After drug was administered, patient experienced the following problems/side effects: blood alkaline phosphatase increased, central line infection, femur fracture, heat stroke, hepatocellular injury, muscle injury, pneumonia, staphylococcal infection, upper respiratory tract inflammation, . CEREZYME dosage: unknown. During the same period patient was treated with VALPROATE, CLONAZEPAM, FAMOTIDINE. Patient was hospitalized. Patient recovered.
CENTRAL LINE INFECTION : Erlotinib Side Effects Report #5688186-2
Physician from UNITED KINGDOM reported ERLOTINIB problem on Mar 21, 2008. Female patient, 78 years of age, was diagnosed with pancreatic carcinoma metastatic and was treated with ERLOTINIB. After drug was administered, patient experienced the following problems/side effects: blood pressure diastolic decreased, central line infection, pericardial effusion, pleural effusion, . ERLOTINIB dosage: (100 MG, QD) , ORAL. During the same period patient was treated with BEVACIZUMAB, GEMCITABINE, OMPRAZOLE, TEICOPLANIN, TIMETNTIN, VANCOMYCIN, LIDOCAINE. Patient was hospitalized. Patient recovered.
CENTRAL LINE INFECTION : Revlimid Side Effects Report #5622931-7
REVLIMID problem was reported by a Physician from GERMANY on Jan 10, 2008. Female patient, 62 years of age, weighting 101.4 lb, was diagnosed with chronic lymphocytic leukaemia and was treated with REVLIMID. After drug was administered, patient experienced the following problems/side effects: atrial fibrillation, central line infection, diarrhoea, haematocrit decreased, haemoglobin decreased, haemorrhage, hypotension, idiopathic thrombocytopenic purpura, . REVLIMID dosage: 25MG, DAILY 21/28, ORAL; 15 MG, 0-1-0-0, ORAL. During the same period patient was treated with DEXAMETHASONE, BACTRIM DS, PANTOPRAZOLE, ALLOPURINOL, VFEND, EUGALAC, AVELOX. Patient was hospitalized. Patient died on 01/06/2008.
CENTRAL LINE INFECTION : Prograf Side Effects Report #5536020-3
Physician from UNITED STATES reported PROGRAF problem on Nov 25, 2007. Female patient, child 8 years of age, weighting 39.46 lb, was diagnosed with renal transplant and was treated with PROGRAF. After drug was administered, patient experienced the following problems/side effects: atelectasis, central line infection, lung disorder, pleural effusion, . PROGRAF dosage: unknown. During the same period patient was treated with ZENAPAX, ASPIRIN, REGLAN, PREVACID, VITAMIN. Patient was hospitalized. Patient recovered.
CENTRAL LINE INFECTION : Intralipid Side Effects Report #5517741-5
INTRALIPID problem was reported by a Consumer or non-health professional from UNITED STATES on Nov 01, 2007. Female patient was diagnosed with parenteral nutrition and was treated with INTRALIPID. After drug was administered, patient experienced the following problems/side effects: catheter related complication, central line infection, device breakage, staphylococcal infection, . INTRALIPID dosage: unknown. Patient recovered.
CENTRAL LINE INFECTION : Intralipid Side Effects Report #5517743-9
Consumer or non-health professional from UNITED STATES reported INTRALIPID problem on Nov 01, 2007. Female patient was diagnosed with parenteral nutrition and was treated with INTRALIPID. After drug was administered, patient experienced the following problems/side effects: blood disorder, central line infection, infusion site extravasation, neonatal disorder, staphylococcal infection, . INTRALIPID dosage: unknown. Patient recovered.
CENTRAL LINE INFECTION : Aldesleukin Side Effects Report #5518136-0
ALDESLEUKIN problem was reported by a Health Professional from UNITED STATES on Nov 13, 2007. Male patient, 55 years of age, weighting 224.9 lb, was diagnosed with metastatic malignant melanoma and was treated with ALDESLEUKIN. After drug was administered, patient experienced the following problems/side effects: blood culture positive, central line infection, . ALDESLEUKIN dosage: 77.76 MILLION UNITS EVERY 8 HOURS IV. During the same period patient was treated with ACETAMINOPHEN, NAFCILLIN, FAMOTIDINE, ONDANSETRON, METOPROLOL, NAPROXEN, POTASSIUM CHLORIDE, PIPERACILLIN AND TAZOBACTAM. Patient was hospitalized. Patient recovered.
CENTRAL LINE INFECTION : Enbrel Side Effects Report #5477041-9
Physician from UNITED STATES reported ENBREL problem on Sept 24, 2007. Female patient was diagnosed with rheumatoid arthritis and was treated with ENBREL. After drug was administered, patient experienced the following problems/side effects: abdominal pain upper, central line infection, gastric cancer, hyperhidrosis, non-hodgkin's lymphoma stage iii, pneumonia, renal failure, thyroid neoplasm, . ENBREL dosage: unknown. During the same period patient was treated with METHOTREXATE. Patient was hospitalized. Patient recovered.
CENTRAL LINE INFECTION : Flolan Side Effects Report #5483779-X
FLOLAN problem was reported by a Physician from JAPAN on Oct 09, 2007. Female patient, 40 years of age, was diagnosed with pulmonary hypertension and was treated with FLOLAN. After drug was administered, patient experienced the following problems/side effects: cardiac failure, central line infection, diarrhoea, inflammation, malaise, productive cough, pyrexia, upper gastrointestinal haemorrhage, . FLOLAN dosage: unknown. During the same period patient was treated with FUROSEMIDE, SPIRONOLACTONE, DIART, TRICHLORMETHIAZIDE, BIOFERMIN R, AMIODARONE, GOODMIN, HALCION. Patient died on 03/03/2004.
CENTRAL LINE INFECTION : Avonex Side Effects Report #5491751-9
Consumer or non-health professional from UNITED STATES reported AVONEX problem on Oct 09, 2007. Male patient, 45 years of age, was diagnosed with multiple sclerosis and was treated with AVONEX. After drug was administered, patient experienced the following problems/side effects: bacterial infection, central line infection, grand mal convulsion, renal failure, . AVONEX dosage: unknown. Patient was hospitalized. Patient recovered.
CENTRAL LINE INFECTION : Cerezyme Side Effects Report #5383683-1
CEREZYME problem was reported by a Physician from UNITED STATES on June 25, 2007. Female patient, 57 years of age, weighting 161.6 lb, was diagnosed with gaucher's disease and was treated with CEREZYME. After drug was administered, patient experienced the following problems/side effects: arthritis infective, central line infection, staphylococcal infection, . CEREZYME dosage: unknown. During the same period patient was treated with CLARITIN, CLONIDINE, DIOVAN, FOSAMAX, LASIX. Patient was hospitalized. Patient recovered.
CENTRAL LINE INFECTION : Remodulin Side Effects Report #5403695-9
Physician from UNITED STATES reported REMODULIN problem on Apr 06, 2007. Female patient, 45 years of age, weighting 124.3 lb, was diagnosed with pulmonary hypertension and was treated with REMODULIN. After drug was administered, patient experienced the following problems/side effects: catheter related infection, central line infection, . REMODULIN dosage: unknown. Patient was hospitalized. Patient recovered.